Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor

This publication has 40 references indexed in Scilit:

• Histone deacetylases (HDACs): characterization of the classical HDAC family
  Biochemical Journal, 2003
• Histone deacetylase as a new target for cancer chemotherapy
  Cancer Chemotherapy and Pharmacology, 2001
• Deacetylation of p53 modulates its effect on cell growth and apoptosis
  Nature, 2000
• Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
  JNCI Journal of the National Cancer Institute, 2000
• Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
  Journal of Biological Chemistry, 2000
• Selective Induction of Cyclin‐Dependent Kinase Inhibitors and Their Roles in Cell Cycle Arrest Caused by Trichostatin A, an Inhibitor of Histone Deacetylase
  Annals of the New York Academy of Sciences, 1999
• Histone acetylation in chromatin structure and transcription
  Nature, 1997
• Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
  Nature, 1995
• Trichostatin A Induces Morphological Changes and Gelsolin Expression by Inhibiting Histone Deacetylase in Human Carcinoma Cell Lines
  Experimental Cell Research, 1994
• Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A
  Experimental Cell Research, 1988